Stine N. Hansen

Stine Normann Hansen is a human biologist and PhD from University of Copenhagen, Denmark. After a Post Doc at Novo Nordisk, she joined NEUmiRNA ApS where she soon became instrumental in establishing and running a unique discovery platform for discovery and preclinical development of RNA therapeutics. Together with this achievement, Stine Normann Hansen successfully specialized into state of the art knowledge on disease pathology in epilepsy which later triggered her nomination as Research Director at NEUmiRNA ApS.